Large granular lymphocytosis after transplantation

Area of Science:

• Hematology
• Transplant Immunology
• Oncology

Background:

• Post-transplant lymphoproliferative disorders (PTLD) are a diverse group of diseases following transplantation.
• Large granular lymphocytic (LGL) lymphocytosis is a PTLD subtype with a variable clinical spectrum.
• The natural history and classification of LGL lymphocytosis in transplant recipients are not well-defined.

Purpose of the Study:

• To review the clinical features, immunophenotypes, etiopathogenesis, diagnosis, outcomes, and treatment of post-transplantation LGL lymphocytosis.
• To enhance understanding of this condition in transplant recipients.
• To provide a basis for improved diagnostic and classification systems.

Main Methods:

• Literature review of studies on post-transplant LGL lymphocytosis.
• Analysis of clinical data, immunophenotypes, and treatment outcomes.
• Evaluation of diagnostic criteria and prognostic factors.

Main Results:

• LGL lymphocytosis is a common post-transplant complication, linked to specific procedural and post-transplant factors.
• Diagnosis requires demonstrating monoclonality, though clonality does not equate to malignancy.
• Patients may present with unexplained cytopenias or autoimmune symptoms.

Conclusions:

• LGL lymphocytosis is a frequent finding post-transplantation and should be considered in relevant clinical scenarios.
• Further research is needed to clarify the long-term prognostic impact of LGLs in transplant patients.
• Improved classification and understanding are crucial for managing this condition.